Low Dose IL-2 for Treating Moderate to Severe Alopecia Areata
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Investigative Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low Dose IL-2 for Treating Moderate to Severe Alopecia Areata. A 52 Weeks Multicenter Prospective Placebo-Controlled Study Assessing Its Impact on T Regulatory Cells and Natural Killer Populations
J Invest Dermatol 2020 Sep 14;[EPub Ahead of Print], F Le Duff, JD Bouaziz, E Fontas, M Ticchioni, M Viguier, O Dereure, P Reygagne, H Montaudié, JP Lacour, S Monestier, MA Richard, T PasseronFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.